Allianz Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Allianz Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.3M	Buy	+841,731	New	+$13.4M	0.01%	908
2022 Q1	–	Sell	-11,965	Closed	-$217K	–	2403
2021 Q4	$217K	Buy	+11,965	New	+$284K	﹤0.01%	2466
2021 Q2	–	Sell	-33,225	Closed	-$432K	–	2387
2021 Q1	$432K	Sell	33,225 -176,147	-84%	-$2.56M	﹤0.01%	1947
2020 Q4	$2.89M	Sell	209,372 -3,170	-1%	-$46.1K	﹤0.01%	1213
2020 Q3	$3.12M	Sell	212,542 -33,013	-13%	-$478K	﹤0.01%	1122
2020 Q2	$3.97M	Buy	245,555 +10,290	+4%	+$165K	﹤0.01%	1311
2020 Q1	$3.38M	Buy	235,265 +19,825	+9%	+$350K	﹤0.01%	1330
2019 Q4	$4.37M	Buy	+215,440	New	+$1.98M	﹤0.01%	1545

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allianz Asset Management's AUPH Position: Q2 2026 in Review

Allianz Asset Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 841,731 shares worth $14.3M. The stake represents 0.01% of the portfolio and ranks #908 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in AUPH as recently as Q4 2021.

Allianz Asset Management first reported a position in AUPH in Q4 2019 and has held it in 8 quarters since. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

Allianz Asset Management held 841,731 shares of Aurinia Pharmaceuticals worth $14.3M as of Q2 2026.
Aurinia Pharmaceuticals was a new Allianz Asset Management position in Q2 2026.
Aurinia Pharmaceuticals made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #908 holding.
Allianz Asset Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.